# FDA recall D-932-2013

> **Hospira Inc.** · Class II · drug recall initiated 2013-08-14.

## Product

Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), packaged in 5 Units x 20 mL Single patient infusion vials per carton, Rx only, Hospira, Inc. Lake Forest, IL 60045, NDC 0409-4699-30

## Reason for recall

Presence of Particulate Matter: Visible particulate embedded in the glass vial was observed and confirmed in a sample bottle during retain sample inspection.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-932-2013
- **Recalling firm:** Hospira Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-08-14
- **Report date:** 2013-09-18
- **Termination date:** 2014-09-18

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lake Forest, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-932-2013

## Citation

> AI Analytics. FDA recall D-932-2013. Retrieved 2026-06-01 from https://api.ai-analytics.org/recall/D-932-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*